Is there a need for a multicenter study to determine the optimal approach to recurrent nephrotic syndrome following renal transplantation?

Pediatric Transplantation

Volumn 5, Issue 6, 2001, Pages 394-397

  Cochat, P ^a   Ranchin, B ^a  

^a EDOUARD HERRIOT HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; IMMUNOGLOBULIN; IMMUNOSUPPRESSIVE AGENT; MYCOPHENOLIC ACID; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; STEROID; TACROLIMUS;

COST EFFECTIVENESS ANALYSIS; DISEASE ASSOCIATION; DRUG CHOICE; EARLY DIAGNOSIS; EDITORIAL; GENE MAPPING; HIGH RISK PATIENT; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY BIOPSY; KIDNEY FAILURE; KIDNEY TRANSPLANTATION; NEPHROTIC SYNDROME; NONHUMAN; PATHOPHYSIOLOGY; PLASMAPHERESIS; PODOCYTE; PROPHYLAXIS; REMISSION; RISK ASSESSMENT; TREATMENT FAILURE; TREATMENT PLANNING;

CHILD; HUMANS; KIDNEY TRANSPLANTATION; MULTICENTER STUDIES; NEPHROTIC SYNDROME; POSTOPERATIVE COMPLICATIONS; RECURRENCE; TREATMENT OUTCOME;

EID: 0035191754     PISSN: 13973142     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1397-3142.2001.00001.x     Document Type: Editorial

References (35)

1. WTI splice-site mutations are rarely associated with primary steroid-resistant focal segmental glomerulosclerosis
2. Familial steroid-resistant nephrotic syndromes: Recent advances
3. Positionally cloned gene for a novel glomerular protein - Nephrin - Is mutated in congenital nephrotic syndrome
4. A locus for adolescent and adult onset familial focal segmental glomerulosclerosis on chromosome lq25-31
5. Donor splice-site mutations in WTI are responsible for Frasier syndrome
6. Congenital microcephaly with hiatus hernia and nephrotic syndrome in two sibs
7. Germline mutations in the Wilms' tumor suppressor gene are associated with abnormal urogenital development in Denys-Drash syndrome
8. Mechanisms of proteinuria: Vascular permeability factor in congenital nephrotic syndrome of the Finnish type
9. In vitro decrease of glomerular heparan sulfate by lymphocytes from idiopathic nephrotic syndrome patients
10. Circulating factor associated with increased glomerular permeability to albumin in recurrent focal segmental glomerulosclerosis
11. 'The FSGS factor': Enrichment and in vivo effect of activity from focal segmental glomerulosclerosis plasma
12. Apolipoproteins prevent glomerular albumin permeability induced in vitro by serum from patients with focal segmental glomerulosclerosis
13. Recurrence of glomerulonephritis following renal transplantation
14. Management of focal segmental glomerulosclerosis: Evidence-based recommendations
15. Management of recurrent nephrotic syndrome after kidney transplantation in children
16. Prediction and treatment of recurrent focal segmental glomerulosclerosis after renal transplantation in children
17. Plasmapheresis treatments for recurrent focal sclerosis in pediatric renal allografts
18. Increased nuclear factor-κB and angiotensinogen gene expression in posttransplant recurrent focal segmental glomerulosclerosis
19. A new method of measuring albumin permeability in isolated glomeruli
20. Effect of plasma fractions from patients with focal segmental glomerulosclerosis on rat proteinuria
21. Loss of living donor renal allograft survival advantage in children with focal segmental glomerulosclerosis
22. Recurrence of focal segmental glomerulosclerosis in transplanted kidneys: Analysis of incidence and risk factors in 59 allografts
23. Recurrent focal glomerulosclerosis: Natural course and treatment with plasma exchange
24. Cyclosporine prevents the increase in glomerular albumin permeability caused by serum from patients with focal segmental glomerular sclerosis
25. Recurrence of focal glomerulosclerosis of allografts in children: The efficacy of intensive plasma exchange therapy before and after renal transplantation
26. Treatment of focal segmental glomerulosclerosis with high-dose cyclosporine A and plasmapheresis
27. Intérêt de la cyclosporine dans le traitement des récidives de néphrose après transplantation rénale
28. Prompt remission of post-renal transplant nephrotic syndrome with high-dose cyclosporine
29. Early recurrent nephrotic syndrome after renal transplantation in children with focal segmental glomerulosclerosis
30. Recurrent nephrotic syndrome after transplantation: Early treatment with plasmapheresis and cyclophosphamide
31. Effect of plasma protein adsorption on protein excretion in kidney-transplant recipients with recurrent nephrotic syndrome
32. Plasmapheresis reduces proteinuria and serum capacity to injure glomeruli in patients with recurrent focal segmental glomerulosclerosis
33. Single-center analysis of early recurrence of nephrotic syndrome following renal transplantation in children
34. Spontaneous remission of proteinuria in recurrent focal glomerulosclerosis. Reappraisal of plasma exchange treatment
35. Impact of recurrent nephrotic syndrome after renal transplantation in young patients